Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidosis - PubMed

Comparative Study

Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidosis

J M Boon et al. Mycoses. 1989 Jun.

Abstract

Ketoconazole suspension (20 mg per ml) was compared with nystatin (100,000 units per ml) in the treatment of oral candidosis in newborns and infants. In all patients Candida infection was proven by culture. Twenty patients were treated with ketoconazole and 15 patients with nystatin. Treatment was discontinued 2 days after clinical cure, or after 3 weeks. The investigator assessed the severity of the thrush and accompanying symptoms at the start of the study and at weekly controls. After one week all 20 patients on ketoconazole (100%) and 8 (53%) patients on nystatin were cured clinically. At the end of the treatment 12 patients on nystatin (80%) were cured. Clinical cure was confirmed by negative culture in 94% of the patients on ketoconazole and in 73% of the patients on nystatin. No side-effects were observed in the patients on ketoconazole. Only in the case of one patient on nystatin, was vomiting observed. This study shows that ketoconazole cures thrush faster and more effectively than nystatin.

Similar articles

• A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.

  Vogler WR, Malcom LG, Winton EF. Vogler WR, et al. Cancer Invest. 1987;5(4):267-73. Cancer Invest. 1987. PMID: 3664330 Clinical Trial.

• Antifungal topical therapy in oral chronic candidosis. A comparative study.

  Lopez-De-Blanc SA, Salati-De-Mugnolo N, Femopase FL, Benitez MB, Morelatto RA, Astrada-De-Verde L, Masih D. Lopez-De-Blanc SA, et al. Med Oral. 2002 Jul-Oct;7(4):260-70. Med Oral. 2002. PMID: 12134127 Clinical Trial. English, Spanish.

• Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular risk.

  Schäfer-Korting M, Blechschmidt J, Korting HC. Schäfer-Korting M, et al. Mycoses. 1996 Sep-Oct;39(9-10):329-39. doi: 10.1111/j.1439-0507.1996.tb00149.x. Mycoses. 1996. PMID: 9009654 Review.

• Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis.

  Lyu X, Zhao C, Yan ZM, Hua H. Lyu X, et al. Drug Des Devel Ther. 2016 Mar 16;10:1161-71. doi: 10.2147/DDDT.S100795. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27042008 Free PMC article. Review.

Cited by

• Antifungal agents for common paediatric infections.

  [No authors listed] [No authors listed] Paediatr Child Health. 2000 Nov;5(8):477-91. doi: 10.1093/pch/5.8.477. Paediatr Child Health. 2000. PMID: 20177562 Free PMC article. No abstract available.

• Antifungal agents for common paediatric infections.

  [No authors listed] [No authors listed] Paediatr Child Health. 2007 Dec;12(10):875-83. doi: 10.1093/pch/12.10.875. Paediatr Child Health. 2007. PMID: 19043507 Free PMC article. No abstract available.

• Mouthwashes in the treatment of oral disease.

  Zegarelli DJ. Zegarelli DJ. Drugs. 1991 Aug;42(2):171-3. doi: 10.2165/00003495-199142020-00001. Drugs. 1991. PMID: 1717218 Review. No abstract available.

• Antifungal agents for common paediatric infections.

  [No authors listed] [No authors listed] Can J Infect Dis Med Microbiol. 2008 Jan;19(1):15-8. Can J Infect Dis Med Microbiol. 2008. PMID: 19145261 Free PMC article. No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley